Dystrophia Myotonika Diagnosis Changes Life for Gothenburg Family
Brothers Sebastian and Alexander Bergström live with dystrophia myotonika in Gothenburg, a hereditary muscle disease diagnosed in 2007 alongside their mother, Lisa, and her sister after their grandfather fell seriously ill, tv4.se reported. The diagnosis provided an explanation for how the family felt, according to Lisa Bergström. Both brothers work within Gothenburg city’s daily activities at Mediabyrån, recording music and audiobooks. Alexander Bergström noted that he suffers from extreme tiredness and has lost most of his friends along the way because they considered him too boring, lazy, or tired. Lisa Bergström expressed ongoing guilt over passing the condition to her sons, calling it the worst part of her experience.
New Research Investigates Varying Disease Progression Rates
Dystrophia myotonika is the most common hereditary muscle disease among adults in Sweden, and no disease-modifying treatment currently exists, tv4.se reported. A new study is analyzing why the condition develops differently across patients. Christopher Lindberg, associate professor and senior physician at the Neuromuscular Center at Sahlgrenska University Hospital, stated that some individuals deteriorate faster while others decline more slowly. Thousands of Swedes live with the hereditary condition, though underreporting is significant and diagnosis can take time. Researchers have tracked a large patient group over several years, measuring changes in muscle and cardiac function to identify factors influencing the disease course.
Symptoms Affecting the Entire Body and Daily Life
The condition impacts the entire body, leading to extreme fatigue, severe stomach problems, and progressive muscle weakness, tv4.se reported. Sahlgrenska University Hospital researchers noted that the illness remains difficult to identify for both patients and healthcare providers, while autism and intellectual disability are common among those born with it. The study aims to pinpoint factors governing the disease trajectory so clinicians can assess which patients will benefit from medications once treatments become available. Christopher Lindberg stated that the research will provide a solid baseline to determine whether a specific patient can utilize a given drug.
Life Expectancy Concerns and Future Uncertainties
The average life expectancy for individuals with dystrophia myotonika is 55 years, according to the National Board of Health and Welfare (Socialstyrelsen), with heart rhythm disorders and breathing difficulties serving as the most common causes of death, tv4.se reported. Lisa Bergström, aged 49, voiced deep concern regarding the future and who will care for her sons if she does not have many years left. Both brothers and their mother live with the knowledge of a shortened lifespan, though Alexander Bergström stated that he lives each day knowing his life may be shorter than most, while choosing not to dwell on it.
Frequently Asked Questions About Dystrophia Myotonika
What is dystrophia myotonika?
Dystrophia myotonika is the most common hereditary muscle disease among adults in Sweden, affecting the entire body with symptoms such as extreme fatigue, severe stomach problems, and progressive muscle weakness. The condition is caused by genetic factors and often goes undiagnosed for long periods due to difficulties in identification within the healthcare system.
How does the new study at Sahlgrenska University Hospital help patients?
Researchers have followed a large patient group over several years, measuring changes in muscle and heart function to understand why the disease progresses at different rates. According to Christopher Lindberg, the results will establish a baseline to determine which patients can benefit from future pharmaceutical treatments.
What is the average life expectancy for those diagnosed?
According to figures from Socialstyrelsen, the average life expectancy for individuals living with dystrophia myotonika is 55 years. Heart rhythm disorders and breathing difficulties represent the most common causes of mortality associated with the condition.